Tag: Artificial Intelligence

monaker-group-receives-formal-approval-to-acquire-57.6%-stake-in-international-financial-enterprise-bank,-planning-fintech-solutions-for-ecommerce-and-digital-media-platforms

Monaker Group Receives Formal Approval to Acquire 57.6% Stake in International Financial Enterprise Bank, Planning Fintech Solutions for eCommerce and Digital Media Platforms

sbl-technologies-becomes-the-first-distributor-of-safe-entry-stations-powered-by-predictmedix-inc.-and-juiceworks

SBL Technologies becomes the first distributor of Safe Entry Stations powered by Predictmedix Inc. and JUICEWORKS

global-customer-analytics-market-to-grow-due-to-growing-product-launches-in-the-retail-sector-by-key-players-–-exclusive-report-with-covid-19-impact-analysis-by-research-dive

Global Customer Analytics Market to Grow due to Growing Product Launches in the Retail Sector by Key Players – Exclusive Report with COVID-19 Impact Analysis by Research Dive

medigus-ltd.-issues-ceo-letter-to-its-shareholders

Medigus Ltd. Issues CEO Letter to its Shareholders

rxlive-limited-closes-$1.4-million-convertible-debenture-financing

RXLive Limited Closes $1.4 Million Convertible Debenture Financing

global-antibiotics-market-to-exceed-$58,7981-million-at-a-cagr-of-4.0%-from-2020-to-2027-–-exclusive-report-[234-pages]-by-research-dive

Global Antibiotics Market to Exceed $58,798.1 Million at a CAGR of 4.0% from 2020 to 2027 – Exclusive Report [234 Pages] By Research Dive

worldwide-cultured-meat-industry-to-2030-–-surge-in-demand-for-alternative-protein-products-is-driving-growth

Worldwide Cultured Meat Industry to 2030 – Surge in Demand for Alternative Protein Products is Driving Growth

insights-on-the-voice-and-speech-recognition-global-market-to-2026-–-by-technology,-deployment-mode,-delivery-methods,-end-use-and-region

Insights on the Voice and Speech Recognition Global Market to 2026 – by Technology, Deployment Mode, Delivery Methods, End-use and Region

landos-biopharma-announces-positive-outcome-of-end-of-phase-2-meeting-with-the-fda-for-omilancor-in-mild-to-moderate-active-ulcerative-colitis-(uc)-patients

Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor in Mild-to-Moderate Active Ulcerative Colitis (UC) Patients

view,-inc.-appoints-technology-pioneer-julie-larson-green-to-board-of-directors

View, Inc. Appoints Technology Pioneer Julie Larson-Green to Board of Directors